Zika Hearing Shows How Vaccine Timelines Are Outbreak-Dependent

NIAID appears on track to have Zika vaccine in widespread testing in late 2017, but development depends in part on the epidemic rate; additional funding is necessary to respond to the outbreak, NIAID director and CDC official testify at Senate and House hearings.

More from Legislation

More from Pink Sheet